Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ | NASDAQ
Chart Builder DCF Calculator
$3.59
+$0.03 (+0.84%)
At close: May 22, 2026, 12:35 PM ET

Market Data

Market Cap
$14.69M
Enterprise Value
$1.32M
Beta
0.32
Average Volume
554.37K
Shares Outstanding (Diluted)
17.85M
Shares Change YoY
3094.89%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
NL0015000LC2

Price Performance

Price Change 1M
N/A
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
209.5%
Price Change 1Y
124.4%
Price Change 3Y
-96.1%
Price Change 5Y
-99.1%
1M CAGR (ann.)
-36.3%
1Y CAGR (ann.)
-83.7%
5Y CAGR (ann.)
N/A
All-Time CAGR
-76.3%

Valuation

PE Ratio
-3.42
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
0.04
PS Ratio
58.68
Forward PS
1.60
PB Ratio
0.72
P/FCF Ratio
-1.46
P/Adj. FCF Ratio
-0.87
P/OCF Ratio
-6.53
EV/Sales
5.25
EV/EBIT
-0.24
EV/EBITDA
-0.09
EV/FCF
-0.13
Earnings Yield
-29.3%
FCF Yield
-68.3%
Adj. FCF Yield
-114.3%

Financial Health

Net Cash
$13.38M
Total Debt
$0
Cash & Short-Term Investments
$13.38M
Total Assets
$23.37M
Current Ratio
5.56
Quick Ratio
5.56
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
683.39
Altman Z-Score
-4.37
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
33.7%
Operating Profit Margin
-6109.7%
EBITDA Margin
-6002.7%
Net Profit Margin
-7542.2%
FCF Margin
-4008.0%
Adj. FCF Margin
-6708.6%
SBC / Revenue
2700.6%
SBC Impact (per share)
-67.4%

Returns

Return on Assets
-80.8%
Return on Equity
-179.8%
Return on Invested Capital
-75.1%
Return on Capital Employed
-75.1%
Return on Tangible Assets
-112.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
-7.6%
Revenue CAGR 5Y
1.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
5.3%
EPS CAGR 5Y
-37.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-1.0%
FCF CAGR 5Y
-12.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
44.4%
Revenue Growth Next 3Y
566.2%
Earnings Date
Apr 14, 2026
EPS Estimate (next Q)
-$1.01
EPS Growth Est (next Q)
-77.0%
Revenue Est (next Q)
$670K
Revenue Growth Est (next Q)
123.3%

Cash Flow

Operating Cash Flow
$-9.9M
Free Cash Flow
$-10.03M
Adj. Free Cash Flow
$-16.8M
FCF Per Share
-$0.56
OCF Per Share
-$0.55
OCF/S Ratio
-3953.1%

Income Statement

Revenue
$250.36K
Gross Profit
$84.41K
Operating Income
$-15.3M
EBITDA
$-15.03M
Net Income
$-18.88M
EPS (Diluted)
-$1.05
Revenue / Employee
$13.18K
Profit / Employee
$-993.84K
Employees
19

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.